It is currently Thu Nov 27, 2014 5:34 pm
Opexa to Present at the Rodman & Renshaw 12th Annual Healthcare Conference on September 14, 2010
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa’s President and Chief Executive Officer, will deliver a corporate presentation at the Rodman & Renshaw 12th Annual Healthcare Conference. The conference will be held September 12-15, 2010 at the New York Palace ...
Total posts 221796 • Total topics 23031 • Total members 14555